Lv4
658 积分 2024-07-10 加入
Savolitinib (Savo) combined with osimertinib (osi) versus chemotherapy (chemo) in EGFR-mutant (EGFRm) and MET-amplification (METamp) advanced NSCLC after disease progression (PD) on EGFR tyrosine kinase inhibitor (TKI): Results from a randomized phase 3 SACHI study
4小时前
已关闭
Orforglipron, an Oral Small-Molecule GLP-1 Receptor Agonist, in Early Type 2 Diabetes
1天前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
5天前
已完结
PD1 × VEGF blocking bispecifics for cancer draw big backing
7天前
已关闭
Response and Resistance to RAS Inhibition in Cancer
7天前
已完结
Research progress of antibody coupling technique in targeted drug delivery
8天前
已完结
Inflammasome components as new therapeutic targets in inflammatory disese
8天前
已关闭
非小细胞肺癌EGFR-TKI耐药机制及治疗的研究进展
8天前
已完结
New promises and challenges in the treatment of advanced non-small-cell lung cancer
8天前
已完结
Non-small-cell lung cancer
8天前
已完结
A Typhoon Center Location Method on Satellite Images Based on Deep Reinforcement Learning
皖公网安备34019202002308
